Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 378, 532 (7 December 1995) | doi:10.1038/378532c0
Anticancer drugs
David M. Reese
- Division of Hematology/Oncology, UCLA School of Medicine, Los Angeles, California 90095, USA
To read this story in full you will need to login or make a payment (see right).
